Sanofi (SNYNF)
Data as of September 4, 2026 · Drug Manufacturers - General
Stockbruh grade: Strong 4/5 metrics rated Sunny
What does Sanofi do?
Sanofi is a global company that focuses on developing therapeutic solutions to improve people's health. They offer an array of pharmaceuticals, vaccines, and consumer healthcare products to address various diseases and conditions. Headquartered in Paris, France, Sanofi collaborates with leading organizations like Stanford University to advance the understanding of immunology and inflammation. With their innovative approach, Sanofi strives to create a healthier future for all! 💊🌍.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛈️ Weak | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $89.27 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Returns have been below average recently — worth reviewing valuation carefully before investing. Sign up free to see the full Stockbruh valuation breakdown.
How the business works
Sanofi is a global company that focuses on developing therapeutic solutions to improve people's health. They offer an array of pharmaceuticals, vaccines, and consumer healthcare products to address various diseases and conditions. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Revenue and earnings are trending upward — Sanofi appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.